The FDA has approved a heart replacement valve that is implanted
via a catheter. Men with heart disease who receive
androgen-deprivation therapy for prostate cancer should have
their heart health monitored carefully.
To continue reading this article, you must login
Subscribe to Harvard Health Online for immediate access to health news and information from Harvard Medical School.